HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Another Court Ruling Rejects RCT Standard For Supplement Claims

This article was originally published in The Rose Sheet

Executive Summary

Two years after Bayer prevailed against FTC's demand for RCTs to substantiate claims for its Phillips Colon Health probiotic, a judge dismisses a class action complaint targeting the product, saying the plaintiffs did not support their argument and their expert expected supplements to be evaluated as drugs.


Related Content

Glutamine Claim Class Action Against GNC Gets Wide Berth For Relevant Studies
Supplement Industry Self-Regulation At Center Stage As Oversight Dims Under Trump
FTC Leaves Supplement Industry Still Waiting For Shift Away From RCT Standard For Claims
FTC Stretched Standards In Enforcement Against Bayer Probiotic Claim


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts